|View printer-friendly version|
|August 12, 2004 5:14 p.m.|
|Teva Comments On Recent Share Price Decline|
Jerusalem, Israel, August 12, 2004 - Commenting on the recent decline in its share price, Israel Makov, President and CEO of Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) said: "We are not aware of developments in our business or any issues with our financial accounting that would explain or support the recent decline in the price of our shares. As we stated last week, at the time of the release of our quarterly financial results, the fundamentals of our business continue to be strong and we remain confident in our business and in our corporate strategy."